The core building blocks of trust must be operationalized for pharma companies to strengthen their social contract, deliver business value, and improve patients’ quality of life.
Trust within the pharmaceutical industry continues to be a puzzling problem. The industry brings innovative medicines to people in need, improving human health and saving lives. This raison d’etre would seem to correlate highly with trust. Yet, the industry consistently struggles with consumer and public trust.
